CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


Us-china Biomedical Technology, Inc.  (CLDS)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
 
   Industry Healthcare Facilities
   Sector  Healthcare
 

CLDS's Revenue Growth by Quarter and Year

Us-china Biomedical Technology,'s Revenue results by quarter and year




CLDS Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter February - - - -
III Quarter November - - - -
II Quarter August - - - -
I Quarter May 0.00 - - -
FY   - - - -



CLDS Revenue first quarter 2019 Y/Y Growth Comment
Us-china Biomedical Technology, Inc. in the first quarter recorded of $ 0.00 millions.

According to the results reported in the first quarter, Us-china Biomedical Technology, Inc. achieved the best Revenue growth in Healthcare Facilities industry. While Us-china Biomedical Technology, Inc.' s Revenue no change of % ranks overall at the positon no. in the first quarter.




CLDS Revenue ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter February - - - -
III Quarter November - - - -
II Quarter August - - - -
I Quarter May - - - -
FY   - - - -

Financial Statements
Us-china Biomedical Technology,'s first quarter 2019 Revenue $ 0.00 millions CLDS's Income Statement
Us-china Biomedical Technology,'s first quarter 2018 Revenue $ 0.00 millions Quarterly CLDS's Income Statement
New: More CLDS's historic Revenue Growth >>


CLDS Revenue (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter February - - - -
III Quarter November - - - -
II Quarter August - - - -
I Quarter May - - - -
FY (Year on Year)   - - - -




Revenue first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019
You need to upgrade your Flash Player

Us-china Biomedical Technology,'s Q/Q Revenue Growth


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CLDS's I. Quarter Q/Q Revenue Comment


Us-china Biomedical Technology,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(May 31 2018)
12 Months Ending
(Feb 28 2018)
12 Months Ending
(Nov 30 2017)
12 Months Ending
(Aug 31 2017)
12 Months Ending
(May 31 2017)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #




Cumulative Revenue growth Comment
In the May 31 2018 period, Us-china Biomedical Technology,'s cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Us-china Biomedical Technology, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #


You need to upgrade your Flash Player




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CLDS's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CLDS's Competitors
Revenue Growth for Us-china Biomedical Technology,'s Suppliers
Revenue Growth for CLDS's Customers

You may also want to know
CLDS's Annual Growth Rates CLDS's Profitability Ratios CLDS's Asset Turnover Ratio CLDS's Dividend Growth
CLDS's Roe CLDS's Valuation Ratios CLDS's Financial Strength Ratios CLDS's Dividend Payout Ratio
CLDS's Roa CLDS's Inventory Turnover Ratio CLDS's Growth Rates CLDS's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending May 31 2018 within Healthcare SectorY/Y Change %Revenue for the quarter ending May 31 2018
Angiodynamics Inc -6.00 %$ -5.999 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

XGTI's Profile

Stock Price

XGTI's Financials

Business Description

Fundamentals

Charts & Quotes

XGTI's News

Suppliers

XGTI's Competitors

Customers & Markets

Economic Indicators

XGTI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071